(0.16%) 5 477.90 points
(0.04%) 39 128 points
(0.49%) 17 805 points
(0.06%) $80.88
(-5.04%) $2.62
(-0.90%) $2 309.80
(-0.36%) $28.77
(2.90%) $1 015.00
(0.33%) $0.936
(0.56%) $10.66
(0.51%) $0.792
(0.86%) $88.24
-5.21% $ 37.88
Live Chart Being Loaded With Signals
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs...
Stats | |
---|---|
Volumen de hoy | 1.26M |
Volumen promedio | 973 540 |
Capitalización de mercado | 1.93B |
EPS | $-0.560 ( Q1 | 2024-05-09 ) |
Próxima fecha de ganancias | ( $-0.230 ) 2024-08-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-16.84 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0820 (0.22%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-12 | Stevens Raymond C | Buy | 50 001 | Ordinary Shares |
2024-06-12 | Stevens Raymond C | Buy | 99 999 | Ordinary Shares |
2024-06-12 | Stevens Raymond C | Sell | 50 001 | Share Option (right to buy) |
2024-06-12 | Stevens Raymond C | Sell | 99 999 | Share Option (right to buy) |
2024-06-06 | Fmr Llc | Buy | 0 | Ordinary Shares |
INSIDER POWER |
---|
17.49 |
Last 56 transactions |
Buy: 9 541 615 | Sell: 7 203 289 |
Volumen Correlación
Structure Therapeutics Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Structure Therapeutics Correlación - Moneda/Commodity
Structure Therapeutics Finanzas
Annual | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-949 174 (0.00 %) |
EPS: | $-2.44 |
FY | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-949 174 (0.00 %) |
EPS: | $-2.44 |
FY | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $-623 258 (0.00 %) |
EPS: | $-1.400 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Structure Therapeutics
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073, a biased agonist, targeting apelin receptor, a GPCR that has been implicated in idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension; and LTSE-2578, an investigational oral small molecule lysophosphatidic acid 1 receptor antagonist for the treatment of IPF. The company was formerly known as ShouTi Inc. Structure Therapeutics Inc. was founded in 2016 and is headquartered in South San Francisco, California.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico